CLINICAL_TRIALS
research
· 2016-10-07
Clinical Trial Update: Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Lung Cancer [Phase 1, Phase 2]
Summary
This clinical trial update describes a Phase 1/Phase 2 study evaluating precision cell immunotherapy combined with chemotherapy in patients with advanced lung c…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ningbo Cancer Hospital | Conditions: Precision Cell Immunotherapy, Chemotherapy | Phase 1, Phase 2 | Status: UNKNOWN